Loss of SMARCA4 expression changes approximately 5% of the mammalian transcriptome19, including changes in the expression of genes associated with NSCLC12, increasing the likelihood for loss of functions that might be redundant in normal cells and non-redundant in tumours lacking SMARCA4. Here, SMARCA4 is linked to neoplasm.